Mirae Asset Global Investments’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-204,430
| Closed | -$4.12M | – | 1817 |
|
2021
Q3 | $4.12M | Buy |
204,430
+39,179
| +24% | +$790K | 0.01% | 904 |
|
2021
Q2 | $6.17M | Buy |
165,251
+18,664
| +13% | +$697K | 0.02% | 766 |
|
2021
Q1 | $3.75M | Buy |
146,587
+66,432
| +83% | +$1.7M | 0.01% | 795 |
|
2020
Q4 | $1.77M | Buy |
80,155
+22,351
| +39% | +$492K | 0.01% | 966 |
|
2020
Q3 | $1.04M | Buy |
57,804
+18,089
| +46% | +$325K | 0.01% | 957 |
|
2020
Q2 | $1.01M | Buy |
39,715
+17,910
| +82% | +$455K | 0.01% | 903 |
|
2020
Q1 | $401K | Buy |
21,805
+2,363
| +12% | +$43.5K | ﹤0.01% | 1096 |
|
2019
Q4 | $428K | Buy |
19,442
+3,250
| +20% | +$71.5K | ﹤0.01% | 1264 |
|
2019
Q3 | $233K | Buy |
+16,192
| New | +$233K | ﹤0.01% | 1356 |
|